WHO ICTRP trial
ALK gene fragmentation detection kit (fluorescence in situ hybridization)…
ChiCTR1900021438 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1900021438 |
|---|---|
| Public title | ALK gene fragmentation detection kit (fluorescence in situ hybridization) clinical trial |
| Scientific title | ALK gene fragmentation detection kit (fluorescence in situ hybridization) clinical trial |
| Primary sponsor | West China Hospital, Sichuan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Diagnostic test |
| Countries | China |
| Conditions | Non-small cell lung cancer |
| Interventions | Gold Standard:Fluorescence in situ hybridization, immunohistochemistry, PCR amplification;Index test:Fluorescence in situ hybridization |
| Registration date | Feb 21, 2019 |
| Target size | Target condition:200;Difficult condition:0 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: